Dapsone (Alvogen Inc.)
Welcome to the PulseAid listing for the Dapsone drug offered from Alvogen Inc.. This Sulfone [EPC],Sulfones [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Alvogen Inc. |
| NON-PROPRIETARY NAME: | dapsone |
| SUBSTANCE NAME: | DAPSONE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Sulfone [EPC],Sulfones [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-06-13 |
| END MARKETING DATE: | 0000-00-00 |
Dapsone HUMAN PRESCRIPTION DRUG Details:
| Item Description | Dapsone from Alvogen Inc. |
| LABELER NAME: | Alvogen Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/1) |
| START MARKETING DATE: | 2016-06-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 47781-333_b4f0b60d-da83-f31b-f874-c985487c7942 |
| PRODUCT NDC: | 47781-333 |
| APPLICATION NUMBER: | ANDA205429 |
Other DAPSONE Pharmaceutical Manufacturers / Labelers:
